Low rate of treatment failure on antiretroviral therapy with tenofovir, lamivudine and zidovudine
Mauss, S.; Milinkovic, A.; Hoffmann, C.; Holm, S.; Berger, F.; MartÃnez, E.; Kuhlmann, B.; Gatell, J.é; Schmutz, G.
Aids 19(1): 101-102
2005
ISSN/ISBN: 0269-9370 PMID: 15627042 DOI: 10.1097/00002030-200501030-00015Document Number: 239517
Document emailed within 0-6 h
Related Documents
Katlama, C.; Ingrand, D.; Loveday, C.; Clumeck, N.; Mallolas, J.; Staszewski, S.; Johnson, M.; Hill, A.M.; Pearce, G.; McDade, H. 1996: Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. a randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group JAMA 276(2): 118-125Staszewski, S.; Keiser, P.; Montaner, J.; Raffi, F.; Gathe, J.; Brotas, V.; Hicks, C.; Hammer, S.M.; Cooper, D.; Johnson, M.; Tortell, S.; Cutrell, A.; Thorborn, D.; Isaacs, R.; Hetherington, S.; Steel, H.; Spreen, W. 2001: Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial JAMA 285(9): 1155-1163
Gartland, M. 2001: AVANTi 3: a randomized, double-blind trial to compare the efficacy and safety of lamivudine plus zidovudine versus lamivudine plus zidovudine plus nelfinavir in HIV-1-infected antiretroviral-naive patients Antiviral Therapy 6(2): 127-134
Goodgame, J.C.; Pottage, J.C.; Jablonowski, H.; Hardy, W.D.; Stein, A.; Fischl, M.; Morrow, P.; Feinberg, J.; Brothers, C.H.; Vafidis, I.; Nacci, P.; Yeo, J.; Pedneault, L. 2000: Amprenavir in combination with lamivudine and zidovudine versus lamivudine and zidovudine alone in HIV-1-infected antiretroviral-naive adults. Amprenavir PROAB3001 International Study Team Antiviral Therapy 5(3): 215-225
Molina, J.M.; Chêuc, G.; Ferchal, F.; Journot, V.; Pellegrin, I.; Sombardier, M.N.; Rancinan, C.; Cotte, L.; Madelaine, I.; Debord, T.; Decazes, J.M. 1999: Results of the ALBi trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients Antiviral Therapy 4(Suppl 3): 71-74
Staszewski, S.; Katlama, C.; Harrer, T.; Massip, P.; Yeni, P.; Cutrell, A.; Tortell, S.M.; Harrigan, R.P.; Steel, H.; Lanier, R.E.; Pearce, G. 1998: A dose-ranging study to evaluate the safety and efficacy of abacavir alone or in combination with zidovudine and lamivudine in antiretroviral treatment-naive subjects Aids 12(16): F197-F202
Moolasart, P.; Likanonsakul, S. 2002: The efficacy of combined zidovudine and lamivudine compared with that of combined zidovudine, lamivudine and nelfinavir in asymptomatic and early symptomatic HIV-infected children Southeast Asian Journal of Tropical Medicine and Public Health 33(2): 280-287
Ozdemir, O.; Saylan, M.; Pakel, H.; Lescrauwaet, B. 2011: PIN8 a Decision Tree Model Comparing Clinical Outcomes of Treatment with Telbivudine with or without "Tenofovir Add-on as Needed" and Lamivudine with or without "Tenofovir Add-on as Needed" in the Treatment of Chronic Hepatitis B Infection in Turkey Value in Health 14(7): A266-A267
Zijenah, L.S.; Kadzirange, G.; Rusakaniko, S.; Kufa, T.; Gonah, N.; Tobaiwa, O.; Gwanzura, C.; Matsikire, E.; Katzenstein, D.A. 2006: A pilot study to assess the immunologic and virologic efficacy of generic nevirapine, zidovudine and lamivudine in the treatment of HIV-1 infected women with pre-exposure to single dose nevirapine or short course zidovudine and their spouses in Chitungwiza, Zimbabwe Central African Journal of Medicine 52(1-2): 1-8
Van Leeuwen, R.; Lange, J.M.; Nijhuis, M.; Schuurman, R.; Reiss, P.; Danner, S.A.; Boucher, C.A. 1997: Results of long-term follow-up of HIV-infected patients treated with lamivudine monotherapy, followed by a combination of lamivudine and zidovudine Antiviral Therapy 2(2): 79-90
Lertcheewakarn, P.; Tongprasert, F. 2014: A comparison of maternal anemia between HIV infected pregnant women receiving zidovudine-based and zidovudine-free highly active Antiretroviral therapy (HAART) Journal of the Medical Association of Thailand 97(4): 361-368
Ter Hofstede, H.J.; Koopmans, P.P.; van Haelst, U.J. 1998: Hepatic steatosis during treatment with zidovudine and lamivudine in an HIV-positive patient Nederlands Tijdschrift Voor Geneeskunde 142(8): 415-419
Currier, J.; Lazzarin, A.; Sloan, L.; Clumeck, N.; Slims, J.; McCarty, D.; Steel, H.; Kleim, J.ör.-P.; Bonny, T.; Millard, J. 2008: Antiviral activity and safety of aplaviroc with lamivudine/zidovudine in HIV-infected, therapy-naive patients: the ASCENT (CCR102881) study Antiviral Therapy 13(2): 297-306
Lailulo, Y.; Kitenge, M.; Jaffer, S.; Aluko, O.; Nyasulu, P.S. 2020: Factors associated with antiretroviral treatment failure among people living with HIV on antiretroviral therapy in resource-poor settings: a systematic review and metaanalysis Systematic Reviews 9(1): 292
Renner, L.A.; Dicko, F.; Kouéta, F.; Malateste, K.; Gueye, R.D.; Aka, E.; Eboua, T.K.; Azondékon, A.; Okomo, U.; Touré, P.; Ekouévi, D.; Leroy, V.; Zannou, M.Djimon.; Ahouada, C.; Akakpo, J.; Ahomadegbé, C.; Bashi-Houeto, J.; Alice, G.; Azo-Kouanou, A.; Houngbe, F.; Maga, H.; Koumakpaï, S.; Alihonou, F.; d'Almeida, M.; Hodonou, I.; Hounhoui, G.; Sagbo, G.; Tossa-Bagnan, Lïla.; Maga, H.; Drabo, J.; Bognounou, Ré.; Kaboré, B.; Ouedraogo, E.; Traore, E.; Zerbo, Béatrice.; Sawadogo, B.Adrien.; Zoungrana, J.; Hema, A.; Sore, I.; Achi 2013: Anaemia and zidovudine-containing antiretroviral therapy in paediatric antiretroviral programmes in the IeDEA Paediatric West African Database to evaluate AIDS Journal of the International Aids Society 16: 18024
Bender, M.A.; Kumarasamy, N.; Mayer, K.H.; Wang, B.; Walensky, R.P.; Flanigan, T.; Schackman, B.R.; Scott, C.A.; Lu, Z.; Freedberg, K.A. 2010: Cost-effectiveness of tenofovir as first-line antiretroviral therapy in India Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 50(3): 416-425
Perno, C.F.; Cozzi-Lepri, A.; Balotta, C.; Forbici, F.; Violin, M.; Bertoli, A.; Facchi, G.; Pezzotti, P.; Angarano, G.; Arici, C.; Narciso, P.; Orani, A.; Raise, E.; Scalzini, A.; Poggio, A.; Ippolito, G.; Moroni, M.; Monforte, A.D. 2001: Impact of mutations conferring reduced susceptibility to lamivudine on the response to antiretroviral therapy Antiviral Therapy 6(3): 195-198
Denneman, L.; Cohen, S.; Godfried, M.H.; van Leeuwen, E.; Nellen, J.F.; Kuijpers, T.W.; Pajkrt, D.; van de Plas, A.; Smit, C.; Weijsenfeld, A.M.; Scherpbier, H.J.; Bunders, M.J. 2017: In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants: author's reply Aids 31(4): 596-598
Foster, C.; Lyall, H.; Olmscheid, B.; Pearce, G.; Zhang, S.; Gibb, D.M. 2009: Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move on from zidovudine? HIV Medicine 10(7): 397-406
Poerksen, G.; Pollock, L.; Moons, P.; Chesshyre, E.; Burger, D.; Khoo, S.; Molyneux, E. 2010: Steady-state nevirapine, lamivudine and stavudine levels in Malawian HIV-infected children on antiretroviral therapy using split Triomune 30 tablets Antiviral Therapy 15(3): 343-350